The partnership between the two companies aims to leverage Epic’s expertise in managing electronic health records (EHRs) and Microsoft’s prowess in natural language processing to create an AI tool that can analyze vast amounts of patient data.

GPT-4, the latest iteration in the GPT series of AI models, will be trained on de-identified EHR data from Epic’s network of over 250 million patients.

The model will be able to identify patterns and correlations in the data, enabling healthcare providers to detect emerging health issues and take preventative action.

The potential applications of GPT-4 are far-reaching, from identifying new disease outbreaks to predicting the efficacy of new treatments.

The model could also be used to improve patient outcomes by providing doctors with real-time insights into a patient’s medical history and potential risk factors.

However, the development of GPT-4 raises important questions around patient privacy and data security.

Epic has stated that all data used to train the model will be de-identified and that the company will adhere to strict privacy regulations.